- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Sclerosis, Osteoporosis in United States
Total 5735 results
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
-
Novartis PharmaceuticalsRecruitingRelapsing-Remitting Multiple SclerosisCanada, United States
-
Abu Dhabi Stem Cells CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited Arab Emirates
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
Cedars-Sinai Medical CenterRecruitingMultiple Sclerosis | Clinically Isolated Syndrome | Multiple Sclerosis, Relapsing-Remitting | Healthy Aging | Neurologic Disorder | Neuromyelitis Optica Spectrum Disorders | Radiologically Isolated Syndrome | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Neurologic... and other conditionsUnited States
-
Scripps HealthWithdrawnMultiple Sclerosis, Relapsing-RemittingUnited States
-
VA Office of Research and DevelopmentActive, not recruitingMultiple SclerosisUnited States, Canada
-
Kessler FoundationHackensack Meridian HealthRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
University of California, San FranciscoGenentech, Inc.; Valhalla FoundationActive, not recruitingClinically Isolated Syndrome | Relapsing Multiple SclerosisUnited States
-
Queen Mary University of LondonMerck Sharp & Dohme LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Eli Lilly and CompanyCompletedRelapsing-Remitting Multiple SclerosisHungary, United States, France, Ukraine, Poland, Germany, Israel, Russian Federation, Czechia, Serbia, Romania, Slovakia, Bulgaria
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
Bristol-Myers SquibbActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
The Cleveland ClinicNational Institutes of Health (NIH)WithdrawnGait Disturbance in Multiple Sclerosis PatientsUnited States
-
Johns Hopkins UniversityUniversity of Pennsylvania; Washington University School of Medicine; Yale University and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingRelapsing Remitting Multiple SclerosisChina, United States, Ukraine, Poland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom, Ireland
-
Queen Mary University of LondonBarts & The London NHS Trust; National Institute for Health Research, United... and other collaboratorsRecruitingProgressive Multiple Sclerosis | Advanced Multiple SclerosisUnited Kingdom
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
Washington University School of MedicineBiogenWithdrawnMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
University of Southern CaliforniaTeva Pharmaceuticals USACompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
The University of Texas Health Science Center,...Microsoft HoustonTerminatedPediatric Onset Multiple Sclerosis (POMS)United States
-
NovartisTerminated
-
University College, LondonLondon School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaboratorsActive, not recruitingSecondary Progressive Multiple Sclerosis (SPMS)United Kingdom
-
Shirley Ryan AbilityLabEdward Hines Jr. VA HospitalCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisAustralia, United States
-
Johns Hopkins UniversityPatient-Centered Outcomes Research InstituteCompletedFatigue in Multiple SclerosisUnited States
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
Apitope Technology (Bristol) Ltd.Aptiv Solutions; ClinStar, LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom, Russian Federation
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
Washington University School of MedicineEMD SeronoActive, not recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
CelgeneNot yet recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of NottinghamNottingham University Hospitals NHS TrustCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Loxo Oncology, Inc.Eli Lilly and CompanyWithdrawnMultiple Sclerosis | Relapsing Multiple SclerosisUnited States, Puerto Rico
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Terry L. WahlsRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of NebraskaCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
University College London HospitalsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Kessler FoundationNational Multiple Sclerosis SocietyCompletedCognitive Impairment in Multiple SclerosisUnited States
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Contineum TherapeuticsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland